Galena Biopharma Inc
Change company Symbol lookup
Select an option...
GALE Galena Biopharma Inc
STLXF Stellar AfricaGold Inc
AMLTF AMP Ltd
GPRK GeoPark Ltd
ATRBF Atrium European Real Estate Ltd
XBGRX Blackrock Energy and Resources Trust
PLSE Pulse Biosciences Inc
PYPL PayPal Holdings Inc
MTGEP MTGE Investment Corp
AVCO Avalon Globocare Corp
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap BlendCompany profile

Galena Biopharma, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302. The Company's NeuVax is in Phase III breast cancer clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies. GALE-301 is in a Phase IIa clinical trial in ovarian and endometrial cancers and in a Phase Ib clinical trial given sequentially with GALE-302. The Company's therapies utilize an immunodominant peptide combined with the immune adjuvant, recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF, Leukine), and work by harnessing the patient's own immune system to seek out and attack any residual cancer cells.

Closing Price
$0.3539
Day's Change
0.0029 (0.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.355
Day's Low
0.35
Volume
(Light)
Volume:
132,612
10-day average volume:
306,462
132,612
  • Prev Close
    0.351
  • Today's Open
    0.35
  • Day's Range
    0.35-0.355
  • Avg Vol (10-day)
    306.5K
  • Last (time)
    3:59p ET 09/22/17
  • Last (size)
    50
  • 52-Wk Range
    0.2568 - 7.70
    LowHigh
  • (09/23/16 - 08/10/17)
    37.80%
  • 96.9%
  • Market Cap
    13.7M
  • Shares Outstanding
    38.6M
  • -0.86
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.8
  • 27.03
  • (% of float 08/15/17)
    12.19

Earnings Calendar and Events Data provided by |Terms of Use| © 2017 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2017. All rights reserved.